Soham D Puvvada

  • 989 Citations
  • 12 h-Index
20102018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Hemophagocytic Lymphohistiocytosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 989 Citations
  • 12 h-Index
  • 24 Article
  • 3 Review article
  • 1 Comment/debate

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study

Puvvada, S. D., Guillén-Rodríguez, J. M., Yan, J., Inclán, L., Heard, K., Rivera, X. I., Anwer, F., Mahadevan, D., Schatz, J. H. & Persky, D. O., Feb 22 2018, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Disease-Free Survival
Drug Therapy
4 Citations

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Kendrick, S., Rimsza, L. M., Scott, D. W., Slack, G. W., Farinha, P., Tan, K. L., Persky, D., Puvvada, S., Connors, J. M., Sehn, L., Gascoyne, R. D. & Schmelz, M., Jan 1 2017, In : Virchows Archiv. 470, 1, p. 113-117 5 p.

Research output: Contribution to journalArticle

2 Citations

Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: A systematic review and meta-analysis

Riaz, I. B., Zahid, U., Kamal, M. U., Husnain, M., McBride, A., Hua, A., Hamadani, A. A., George, L., Zeeshan, A., Sipra, Q. U. A. R., Raina, A., Rahman, B., Puvvada, S. & Anwer, F., Sep 1 2017, In : Immunotherapy. 9, 12, p. 979-993 15 p.

Research output: Contribution to journalReview article

Meta-Analysis
B-Lymphocytes
Hematologic Neoplasms
T-Lymphocytes
Neurotoxicity Syndromes
1 Citations

A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O., Sep 5 2017, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Lymphoma
Lymphoma, Large B-Cell, Diffuse
Major Histocompatibility Complex
Biomarkers
Histone Deacetylases
12 Citations

Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review

Berger, G. K., McBride, A., Lawson, S., Royball, K., Yun, S., Gee, K., Bin Riaz, I., Saleh, A. A., Puvvada, S. & Anwer, F., Jan 1 2017, In : Critical Reviews in Oncology/Hematology. 109, p. 42-50 9 p.

Research output: Contribution to journalReview article

Non-Hodgkin's Lymphoma
Therapeutics
Sezary Syndrome
Anaplastic Large-Cell Lymphoma
Neoplasms